"USFDA gives nod to drugs of 3 major Indian listed companies:
1. Zydus- 10 mg ezetimibe tablets USP for high cholesterol
2. Lupin- 5 mg, 10 mg, 15 mg, 20 mg and 30 mg Oxycodone Hydrochloride Tablets USP for severe pain
3. Glenmark- 2.5 mg and 5 mg of Saxagliptin tablets, 2.5 mg and 5 mg of AstraZeneca AB and the generic version of Onglyza tablets, a dipeptidyl peptidase-4 (DPP-4) inhibitor used to treat Type II Diabetes"